(1 - 16 from 31
)
The Business Matrix: Tuesday 31 July 2012
www.independent.co.uk
[The Independent] - Cillit Bang, Nurofen and Durex are selling well for Reckitt Benckiser. Reckitt managed to avoid the profit warnings issued by its rival Procter & Gamble as investing in its biggest brands helped overcome economic troubles in Europe. Half-year profits
Google News: London open: Central bank hopes drive gains early on
[ShareCast] - Cillit Bang maker Reckitt Benckiser fell after reported revenues fell 1% in the second quarter. Nevertheless, net revenue in the first half of the year was £4669m, up 1% year-on-year using actual exchange rates and up 4% on a constant exchange rates
Guardian: Reckitt Benckiser slips despite Cillit Bang maker's profits edging higher
[The Guardian (blog)] - Reckitt Benckiser is the biggest faller in a rising FTSE 100 after the Cillit Bang maker despite outperforming some of its consumer goods peers. The company unveiled a 2% rise in half year operating profits to £1.12bn, compared to a recent warning from
Reckitt Benckiser Q2 Revenue Edges Down
www.rttnews.com
[RTT News] - On a category basis, the company experienced an improving trend on Health and Hygiene powerbrands of Dettol, Lysol, Cillit Bang, Harpic, Finish and Veet all performed well. In the quarter, Europe and North America or ENA segment reported a 6 percent
sorted by relevance / date